| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |